ALS

Biotech By Adam Feuerstein

Brainstorm’s cell therapy for ALS fails study, but company sees signs of efficacy — and may push for approval

Biotech By Adam Feuerstein

Cytokinetics pushes ahead with ALS drug despite negative clinical trial outcome

Health By Ike Swetlitz

Head trauma link to ALS strengthened with findings of NFL player Kevin Turner’s autopsy

First Opinion By Judith Graham

My sister made her end-of-life wishes clear. Then dementia took hold

Health By Leah Samuel

Architect with ALS designs a residence he can control with just blinks

Business By Leah Samuel

ALS patient takes on one final fight: jump-starting research

Health By Priyanka Dayal McCluskey — Boston Globe

For ALS patients robbed of speech, a new way of ‘speaking’